hIL4-Tg(M-NSG)

品系全名

NOD.Cg-PrkdcscidIl2rgem1Tg(hIL4)Smoc

目錄號

NM-KI-215004

品系狀態(tài)

胚胎凍存

導(dǎo)出PDF

基因信息

基因名
Il4

品系描述

利用轉(zhuǎn)基因技術(shù)將人源IL4基因表達框整合到小鼠基因組中,從而表達人源IL4。

驗證數(shù)據(jù)

image.png

Fig1. Detection of hIL4 expression by RT-PCR.?

Heterozygous:? one band at 223 bp with primers F1/R1(hIL4);?

Abbr. M, DNA marker; HO, homozygous; HE, heterozygous; WT, wild type.

image.png

Fig 2. Detection of hIL4 expression in serum by ELISA.?

Abbr. HO, homozygous; HE, heterozygous; WT, wild type.、

image.png

Fig 3. Body weight growth curve of huPBMC-M-NSG-hIL4 mice.?

image.png

Fig 4. Survival rate of huPBMC-M-NSG-hIL4 mice.?

image.png

Fig 5. GvHD scores of huPBMC-M-NSG-hIL4 mice.?

image.png

Fig 6. Percentage of hCD45-positive cells in peripheral blood of huPBMC-M-NSG-hIL4 mice.?

image.png

Fig 7. Flow analysis of peripheral blood lymphocyte subpopulations in the huPBMC-M-NSG-hIL4 model. Human PBMCs (1E7) were injected intravenously into hIL4-Tg(M-NSG) mice (female, 6-8 weeks old, n=10). Blood from mice at different time points after implantation of human PBMCs was taken for flow cytometric analysis.



你也可能感興趣

Tamoxifen誘導(dǎo)Cre-ERT2小鼠 使用指南

Cre-ERT2在無Tamoxifen誘導(dǎo)的情況下,在細胞質(zhì)內(nèi)處于無活性狀態(tài);當Tamoxifen誘導(dǎo)后,Tamoxifen的代謝產(chǎn)物4-OHT(雌激素類似物)與ERT結(jié)合,可使Cre-ERT2進核發(fā)揮Cre重組酶活性。

查看
【小鼠大學(xué)問】基因工程小鼠的命名規(guī)則

常見的基因工程小鼠可以分為兩種命名方式,包括基因定點修飾的小鼠命名,比如:敲除、敲入、點突變等等,和隨機轉(zhuǎn)基因的小鼠命名。

查看